Dentists in Nokomis, FL Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. John Dempsey Ivey, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1358 Ewing St, Nokomis, FL 34275 Phone: 941-484-6716 Fax: 941-484-6716 |
 Dr. Jennifer Lynn Jaworski, DMD PA Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2420 Tamiami Tr N, Nokomis, FL 34275 Phone: 941-466-7226 Fax: 941-966-5251 |
Keith Blessitt, D.M.D. Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 2420 Tamiami Trl N Ste B, Nokomis, FL 34275 Phone: 941-966-7226 Fax: 941-966-5251 |
Nicole Griffith Dentist Medicare: Not Enrolled in Medicare Practice Location: 1200 Tamiami Trl N, Nokomis, FL 34275 Phone: 941-244-4778 |
News Archive
Quest Diagnostics agrees to manage laboratory operations for Barnabas Health hospitals
Quest Diagnostics, the world's leading provider of diagnostic information services, and Barnabas Health, New Jersey's largest not-for-profit integrated health care delivery system, are teaming up to enhance quality and value of diagnostic services to patients and their doctors through an agreement for Quest to manage laboratory operations for Barnabas Health hospitals.
Light-activated nanoparticles can provide crucial boost in effectiveness for antibiotics
Light-activated nanoparticles, also known as quantum dots, can provide a crucial boost in effectiveness for antibiotic treatments used to combat drug-resistant superbugs such as E. coli and Salmonella, new University of Colorado Boulder research shows.
Benzodiazepines and related drugs frequently used before and after diagnosis of Alzheimer's disease
Benzodiazepines and related drugs are initiated frequently in persons with Alzheimer's disease already before the diagnosis, and their use becomes even more common after the diagnosis, shows a recent study from the University of Eastern Finland.
Rowan University, Bamboo Therapeutics partner to combat Canavan disease
Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.
› Verified 3 days ago
Pharmacists
Occupational Therapists
Dentists
Clinical Social Workers
Counselors
Psychologists